title: [Multidisciplinary meeting about the use of direct oral anticoagulants in nonvalvular atrial fibrillation].
abstract: Knowing the real impact of atrial fibrillation in the stroke, the Sociedad Mexicana of Electrofisiología y Estimulación Cardiaca (SOMEEC) had the initiative to develop a multidisciplinary meeting of experts the with the purpose to update the available scientific evidence from clinical practice guidelines, meta-analyses, controlled clinical trials, and complementing with the experience and views of a group of experts. To meet this goal, SOMEEC gathered a group of specialists in the area of cardiology, electrophysiology, neurology and hematology that given their experience in certain areas, they share the scientific evidence with the panel of experts to leave open a discussion about the information presented in this article. This document brings together the best scientific evidence available and aims to be a useful tool in the decision to use of new oral anticoagulants in nonvalvular atrial fibrillation and ischemic heart disease, or relating to the management of patients with stroke or renal failure, and even those that will be submitted to elective surgery and invasive procedures. In the same, they handled comparative schemes of follow-up and treatment which simplifies the decision making by the specialists participants.
authors: Sociedad Cardiovascular y Arritmias, Aguascalientes, México. Electronic address: humbertorodriguezr2@gmail.com.
authors: Humberto
authors: H
authors: Rodríguez-Reyes
authors: Clínica de Enfermedad Vascular Cerebral, Instituto Nacional de Neurología y Neurocirugía, Ciudad de México, México.
authors: Antonio
authors: A
authors: Arauz-Góngora
authors: Departamento de Medicina Interna, Hospital Médica TEC 100, Querétaro, México.
authors: Enrique
authors: E
authors: Asensio-Lafuente
authors: Instituto de Corazón CIMA Hermosillo, Sonora, México.
authors: Manuel de Jesús
authors: MJ
authors: Celaya-Cota
authors: Instituto Cardiovascular de Guadalajara, Guadalajara, México.
authors: Alejandro
authors: A
authors: Cordero-Cabra
authors: UMAE Hospital de Especialidades «Dr. Antonio Fraga Mouret», Centro Médico Nacional La Raza, Ciudad de México, México.
authors: Milton
authors: M
authors: Guevara-Valdivia
authors: Departamento de Hematología, Clínica de anticoagulantes, Instituto Nacional de Cardiología «Ignacio Chávez», Ciudad de México, México.
authors: Raúl
authors: R
authors: Izaguirre-Avila
authors: Servicio de Arritmias, Centro Médico IMSS, León Guanajuato, México.
authors: Susano
authors: S
authors: Lara-Vaca
authors: Servicio de Cardiología, Centro Médico Nacional de Occidente IMSS, Guadalajara, México.
authors: Vitelio
authors: V
authors: Mariona-Moreno
authors: Servicio de Electrofisiología, Centro Médico Nacional Siglo XXI, Ciudad de México, México.
authors: Enrique
authors: E
authors: Martínez-Flores
authors: Departamento de Electrocardiología, Instituto Nacional de Cardiología «Ignacio Chávez», Ciudad de México, México.
authors: Santiago
authors: S
authors: Nava-Townsend
authors: Instituto de Cardiología y Medicina vascular del TEC de Monterrey, Monterrey, México.
authors: Gerardo
authors: G
authors: Pozas-Garza
authors: Departamento de Electrofisiología, Centro Médico Nacional 20 de Noviembre, Ciudad de México, México.
authors: Gerardo
authors: G
authors: Rodríguez-Diez
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage* / Q000494:pharmacology; D001281:Atrial Fibrillation / Q000150:complications*; D006801:Humans; D020521:Stroke / Q000209:etiology* / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants
keywords: Anticoagulantes orales; Apixaban; Apixabán; Atrial fibrillation; Dabigatran; Dabigatrán; Fibrilación auricular; Mexico; México; Oral anticoagulants; Rivaroxaban; Rivaroxabán; Sociedad Mexicana de Electrofisiología y Estimulación Cardiaca